Multimedia
View More
Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270
Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/
On-demand Clinical Care Options (CCO) Webcast on corneal toxicity in patients receiving antibody-drug conjugate therapy for the treatment of cancer
Asim V. Farooq, MD
Sagar Lonial, MD
Anthony Perissinotti, PharmD, BCOP
Physicians:
maximum of 1.0 AMA PRA Category 1 Credit™
Released: January 20, 2021
Expired:
January 19, 2022
Downloadable slides with notes from pharmacist and nursing experts on maintenance avelumab, enfortumab vedotin and erdafitinib for urothelial carcinoma, from CCO
Kinjal Patel, PharmD, BCOP
Susan Roethke, CRNP, MSN, AOCN, ANP-BC
Released: January 11, 2021
Simplified treatment option resource for advanced urothelial carcinoma highlighting recently approved agents, from Clinical Care Options (CCO)
Kinjal Patel, PharmD, BCOP
Susan Roethke, CRNP, MSN, AOCN, ANP-BC
Released: January 7, 2021
CCO guide on signs and symptoms of potential AEs for your patients receiving erdafitinib or enfortumab vedotin
Kinjal Patel, PharmD, BCOP
Susan Roethke, CRNP, MSN, AOCN, ANP-BC
Released: January 6, 2021
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.